John Mendelsohn

Cancer researcher John Mendelsohn, M.D. is the president of the MD Anderson Cancer Center at the University of Texas. We will talk about new developments in cancer treatment. Mendelsohn created a new cancer drug, known as C225. The drug shows great promise in treating a number of cancers by halting the growth of cancer cells. There has been an explosion in the number of cancer drugs in recent years.